Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CollPlant Biotechnologies (CLGN) FCF Margin (2018 - 2025)

CollPlant Biotechnologies filings provide 8 years of FCF Margin readings, the most recent being 4866.67% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 279045.0% to 4866.67% in Q4 2025 year-over-year; TTM through Dec 2025 was 396.08%, a 224664.0% increase, with the full-year FY2025 number at 396.08%, up 224664.0% from a year prior.
  • FCF Margin hit 4866.67% in Q4 2025 for CollPlant Biotechnologies, down from 3735.06% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 77.52% in Q1 2021 to a low of 82700.0% in Q3 2024.
  • Median FCF Margin over the past 5 years was 1496.39% (2024), compared with a mean of 6988.51%.
  • Biggest five-year swings in FCF Margin: crashed -8270002bps in 2024 and later soared 7896494bps in 2025.
  • CollPlant Biotechnologies' FCF Margin stood at 320.0% in 2021, then plummeted by -6594bps to 21420.69% in 2022, then skyrocketed by 97bps to 707.69% in 2023, then tumbled by -193bps to 2076.22% in 2024, then plummeted by -134bps to 4866.67% in 2025.
  • The last three reported values for FCF Margin were 4866.67% (Q4 2025), 3735.06% (Q3 2025), and 1361.45% (Q2 2025) per Business Quant data.